Cerebral venous-sinus thrombosis: A case series analysis

Iranian Journal of Medical Sciences

Volumn 36, Issue 3, 2011, Pages 178-182

  Ashjazadeh, Nahid ^a   Haghighi, Afshin Borhani ^b   Poursadeghfard, Maryam ^b   Azin, Hoseinjan ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Intracranial sinus thrombosis; Oral contraceptives; Stroke

Indexed keywords

HEPARIN; ORAL CONTRACEPTIVE AGENT; WARFARIN;

ADULT; ANALYTICAL RESEARCH; ARTICLE; CASE STUDY; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; COMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DESCRIPTIVE RESEARCH; DIGITAL SUBTRACTION VENOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEADACHE; HIGH RISK POPULATION; HUMAN; IRAN; LIVER VEIN THROMBOSIS; MAGNETIC RESONANCE VENOGRAPHY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL CONTRACEPTION; PAPILLEDEMA; PATIENT EDUCATION; PHLEBOGRAPHY; PROGNOSIS; RELIGION; RETROSPECTIVE STUDY; RISK REDUCTION; SEIZURE; STUPOR; SUBARACHNOID HEMORRHAGE; SUPERIOR SAGITTAL SINUS; TREATMENT DURATION;

EID: 80955125813     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Siddiqui FM, Kamal AK. Incidence and epidemiology of cerebral venous thrombosis. J Pak Med Assoc 2006; 56: 485-7.
2. Saadatnia M, Tajmirriahi M. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis. Acta Neurol Scand 2007; 115: 295-300.
3. Azin H, Ashjazadeh N. Cerebral venous sinus thrombosis-clinical features, predisposing and prognostic factors. Acta Neurol Taiwan 2008; 17: 82-7.
4. Saadatnia M, Mousavi SA, Haghighi S, Aminorroaya A. Cerebral vein and sinus thrombosis in Isfahan-Iran: a changing profile. Can J Neurol Sci 2004; 31: 474-7.
5. Rahimi Z, Mozafari H, Bigvand AH, et al. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden. Clin Appl Thromb Hemost 2010; 16: 430-4.
6. Ferro JM, Canhão P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664-70.
7. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005; 352: 1791-8.
8. Masuhr F, Mehraein S, Einhäupl K. Cerebral venous and sinus thrombosis. J Neurol 2004; 251: 11-23.
9. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992; 10: 87-111.
10. Daif A, Awada A, Al-Rajeh S, et al. Cerebral venous thrombosis in adults: A study of 40 cases from Saudi Arabia. Stroke 1995; 26: 1193-5.
11. Saadatnia M, Haghighi S, Ziaei J, et al. Oral contraceptive pills misuse and cerebral vein sinus thrombosis: a growing health problem in Isfahani women. J Neurol 2004; 251: 300.
12. Nagaraja D, Noone ML, Bharatkumar VP, et al. Homocysteine, folate and vitamin B(12) in puerperal cerebral venous thrombosis. J Neurol Sci 2008; 272: 43-7.
13. Cantu C, Alonso E, Jara A, et al. Hyprehomocysteinomia, Low folate and vitamin B12 concentration, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 2004; 35: 1790-4.
14. Davatchi F, Shahram F, Akbarian M, et al. Behcet's Disease: Analysis of 3443 cases. APLAR Journal of Rheumatology 1997; 1: 2-5.
15. Ashjazadeh N, Borhani Haghighi A, Samangooie Sh, Moosavi H. Neuro-Behcet's disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behcet's disease in 96 Iranian patients. Exp Mol Pathol 2003; 74: 17-22.
16. Borhani-Haghighi A, Samangooie S, Ashjazadeh N, et al. Neurological manifestations of Behcet's disease. Saudi Med J 2006; 27: 1542-6.
17. Uthman I, Khalil I, Sawaya R, et al. Lupus anticoagulant, factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis. Clin Rheumatol 2004; 23: 362-3.
18. Lee MK, Kim JH, Kang HR, et al. Systemic lupus erythematosus complicated with cerebral venous sinus thrombosis: a report of two cases. J Korean Med Sci 2001; 16: 351-4.
19. Borhani-Haghighi A, Sabaeiyan B, Nejabat M, Omrani G. Coexistence of Hyperhomocysteinemia and Protein C Deficiency in the Development of Sinus Thrombosis a Case Report. Iranian Journal of Endocrinology and Metabolism 2006; 8: 345-51.[In Persian]
20. Canhão P, Ferro JM, Lindgren AG, et al. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005; 36: 1720-5.
21. Hameed B, Syed NA. Prognostic indicators in cerebral venous sinus thrombosis. J Pak Med Assoc 2006; 56: 551-4.